Product category:
Reference standards
News Release from: MIP Technologies
Edited by the Laboratorytalk Editorial
Team on 28 February 2006
At the boundary between chemistry and
materials
MIP Technologies will be present at Pittcon 2006 (Orlando, March 12-17) - where it will be making a major announcement - and Analytica 2006 (Munich, April 25-28).
MIP Technologies has several R+D contracts with customers in pharma/biotech, food and other industries For example, the company has been working with FeF Chemicals, a wholly-owned subsidiary of Novo Nordisk, and has an ongoing contract with the US Environmental Protection Agency (EPA) for the development of MIP based solid-phase extraction materials for the extraction of pyrethroid pesticide residues from composite dietary samples
This article was originally published on Laboratorytalk on 8 Mar 2006 at 8.00am (UK)
Related stories
Discovery for selective separation materials
Library of molecularly imprinted polymer (MIP) sorbents with a range of functional characteristics will be used to discover 'hits' for customers who have demands in selective separation or extraction
Improved SPE for banned antibiotic Chloramphenicol
Product is a solid-phase extraction (SPE) sorbent specific for Chloramphenicol, a broad spectrum antibiotic used in animal and fish production because of antibacterial and pharmacokinetic properties
After a collaboration with the Centers for Disease Control and Prevention (CDC) in Atlanta, MIP Technologies now supplies CDC with analytical MIP based SPE products.
The company has also entered into several collaboration agreements with major corporations which are still confidential.
MIP Technologies is working at the boundary between chemistry and material science using innovative proprietary technology.
In addition to unique know-how and intellectual property, the company has developed a technology platform enabling a rapid and economic development of custom made separation phases with superior properties.
It was founded by researchers from the European Research Network, Mica (Molecular Imprinting in Chemical Analysis) and has a strategic relationship with Professor Borje Sellergren at the University of Dortmund for cutting-edge research.
MIP Technologies is located in Lund, Sweden, and has 17 employees.
The privately-held company is owned by Teknoseed, Malmohus Invest, Catella Healthcare Investment, founders and management.
The company completed a SEK 30million (euro 3.25million) financing round, with Catella Healthcare Investments as lead investor, in August 2005.
• MIP Technologies: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
